Purpose: It has been shown that increasing bone marrow lesions (BMLs) in osteoarthritis (OA) are a predictor of cartilage loss. It is not known if incident and progressive BMLs exhibit a different risk of follow-up (FU) cartilage loss at 30 months when compared to stable BMLs. The risk of cartilage loss in subregions of regressing BMLs to date has not been investigated. It is further not known if cartilage loss at FU is associated with baseline (BL) BML volume. Hence, we examined the association of BL and 30-months FU subchondral bone marrow edema status with risk of cartilage loss in the same subregion at FU. Methods: The MOST study is a longitudinal observational multicenter study of OA including subjects with radiographic/clinical OA or being at risk of developing it. All patients with available BL and 30-months FU MRIs were included. The study population was subdivided concerning BL and FU BML status in knee subregions: 1. No BML at BL and at FU 2. No BML at BL and incident BML 3. Prevalent BML at BL and decrease of BML 4. Prevalent BML at BL and increase of BML 5. Prevalent BML at BL and no change in BML. The latter subgroup was chosen as the reference group for analysis. The MRI protocol included triplanar proton-density weighted fatsuppressed FSE sequences. MRI was performed at a 1.0 T extremity system (ONI, OrthOne™. Subchondral BML volume was scored semi-quantitatively from 0 to 3 in 14 subregions of the knee. Cartilage was scored from 0 to 6 in the same subregions. A logistic regression model was applied for correlations of BML status at BL and FU with cartilage status at 30 months. Any cartilage score change ≥0.5 was defined as increase. Adjustment was performed for age, sex and BMI. A subanalysis by BML volume at baseline was performed to determine its predictive value concerning cartilage loss at 30 months. Results: 413 knees were included and 5309 subregions analyzed. 440 BMLs were observed in a subregion at baseline. Out of these 34.3% did not change, 49.8% showed regression and 15.9% showed progression. 281(6.0%) subregions in the absent BML group, 101(55.4%) in the incident BML group, 62(28.3%) in the decreasing BML group, 36(51.4%) in the progressive BML group and 41(27.1%) in the stable BML group showed progres-Abstract 27 - Table 1 . Association of BML status at BL and 30-months follow-up with risk of cartilage loss at FU
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